• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五种抗菌化合物治疗成人霍乱的对比试验。

Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.

作者信息

Khan W A, Begum M, Salam M A, Bardhan P K, Islam M R, Mahalanabis D

机构信息

Clinical Sciences Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka.

出版信息

Trans R Soc Trop Med Hyg. 1995 Jan-Feb;89(1):103-6. doi: 10.1016/0035-9203(95)90675-4.

DOI:10.1016/0035-9203(95)90675-4
PMID:7747291
Abstract

To compare the efficacy of ciprofloxacin, erythromycin, nalidixic acid and pivmecillinam in the treatment of tetracycline-resistant strains of Vibrio cholerae O1 in adults, a randomized, open, clinical trial was conducted. A tetracycline group was used for comparison. Seventy-five adult men infected with V. cholerae O1 were randomly assigned to receive either 400 mg pivmecillinam or 500 mg of one of each of the other drugs. Ciprofloxacin was given every 12 h and the others every 6 h for 3 d. The mean total stool volume per kg was 155 mL for the ciprofloxacin group, 212 mL for the erythromycin and pivmecillinam groups, 246 mL for nalidixic acid, and 293 mL for tetracycline. The difference between ciprofloxacin and tetracycline was significant (P = 0.045). After 72 h, diarrhoea had stopped in 14 patients (93%) in the ciprofloxacin group and 12 (80%) in the erythromycin group, compared to 5 (42%) of those receiving tetracycline (P = 0.006 and 0.049, respectively). Bacteriological clearance was 100% at 24 h in patients treated with ciprofloxacin compared to 20% and 8.3% (P < 0.001 for both comparisons) in the erythromycin and tetracycline groups. Ciprofloxacin in conjunction with appropriate fluid therapy was the most effective treatment for cholera in adults; erythromycin was the next best.

摘要

为比较环丙沙星、红霉素、萘啶酸和匹美西林对成人四环素耐药性霍乱弧菌O1菌株的治疗效果,进行了一项随机、开放的临床试验。设立四环素组作为对照。75名感染霍乱弧菌O1的成年男性被随机分配接受400mg匹美西林或500mg其他药物中的一种。环丙沙星每12小时给药一次,其他药物每6小时给药一次,持续3天。环丙沙星组每千克体重的平均粪便总量为155mL,红霉素和匹美西林组为212mL,萘啶酸组为246mL,四环素组为293mL。环丙沙星与四环素之间的差异具有统计学意义(P = 0.045)。72小时后,环丙沙星组14名患者(93%)腹泻停止,红霉素组12名患者(80%)腹泻停止,而接受四环素治疗的患者中只有5名(4)腹泻停止(P分别为0.006和0.049)。环丙沙星治疗的患者在24小时时细菌清除率为100%,而红霉素组和四环素组分别为20%和8.3%(两组比较P均<0.001)。环丙沙星联合适当的液体疗法是治疗成人霍乱最有效的方法;红霉素次之。

相似文献

1
Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.五种抗菌化合物治疗成人霍乱的对比试验。
Trans R Soc Trop Med Hyg. 1995 Jan-Feb;89(1):103-6. doi: 10.1016/0035-9203(95)90675-4.
2
Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.环丙沙星与强力霉素单剂量治疗霍乱弧菌01或0139引起的霍乱的随机对照比较
Lancet. 1996 Aug 3;348(9023):296-300. doi: 10.1016/s0140-6736(96)01180-4.
3
Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.环丙沙星治疗对环丙沙星敏感性降低的霍乱弧菌O1所致霍乱的疗效
PLoS One. 2015 Aug 13;10(8):e0134921. doi: 10.1371/journal.pone.0134921. eCollection 2015.
4
A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.一项比较红霉素、氨苄青霉素和四环素治疗儿童霍乱疗效的随机临床试验。
Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):460-2. doi: 10.1016/s0035-9203(98)91094-x.
5
Comparative trial of erythromycin and sulphatrimethoprim in the treatment of tetracycline-resistant Vibrio cholerae O1.红霉素与复方磺胺甲恶唑治疗四环素耐药性霍乱弧菌O1的对比试验
Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):836-8. doi: 10.1016/0035-9203(89)90347-7.
6
Clinical features, antimicrobial susceptibility and toxin production in Vibrio cholerae O139 infection: comparison with V. cholerae O1 infection.霍乱弧菌O139感染的临床特征、抗菌药敏性及毒素产生:与霍乱弧菌O1感染的比较
Trans R Soc Trop Med Hyg. 1996 Jul-Aug;90(4):402-5. doi: 10.1016/s0035-9203(96)90522-2.
7
Antimicrobial susceptibility pattern of Vibrio cholerae O1 strains during two cholera outbreaks in Dar es Salaam, Tanzania.坦桑尼亚达累斯萨拉姆两次霍乱疫情期间霍乱弧菌O1菌株的抗菌药敏模式
East Afr Med J. 2000 Jul;77(7):350-3.
8
Ciprofloxacin for the treatment of cholera: a randomized, double-blind, controlled clinical trial of a single daily dose in Peruvian adults.
Clin Infect Dis. 1995 Jun;20(6):1485-90. doi: 10.1093/clinids/20.6.1485.
9
Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children.匹美西林与萘啶酸治疗儿童急性志贺菌病的比较。
Scand J Gastroenterol. 1994 Apr;29(4):313-7. doi: 10.3109/00365529409094842.
10
Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.四环素治疗由O139孟加拉霍乱弧菌引起的重症霍乱。
J Health Popul Nutr. 2002 Mar;20(1):18-25.

引用本文的文献

1
Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.环丙沙星治疗对环丙沙星敏感性降低的霍乱弧菌O1所致霍乱的疗效
PLoS One. 2015 Aug 13;10(8):e0134921. doi: 10.1371/journal.pone.0134921. eCollection 2015.
2
Antimicrobial drugs for treating cholera.用于治疗霍乱的抗菌药物。
Cochrane Database Syst Rev. 2014 Jun 19;2014(6):CD008625. doi: 10.1002/14651858.CD008625.pub2.
3
Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial.
孟加拉国霍乱患儿补锌治疗:随机对照试验。
BMJ. 2008 Feb 2;336(7638):266-8. doi: 10.1136/bmj.39416.646250.AE. Epub 2008 Jan 8.
4
Case studies in cholera: lessons in medical history and science.霍乱病例研究:医学史与科学中的经验教训
Yale J Biol Med. 1999 Nov-Dec;72(6):393-408.
5
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.环丙沙星。对其药理学、治疗效果及耐受性的最新综述。
Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.